Posts by Sandra Ansanay-Alex
Izar by Mindmaze, a new smart device to improve hand rehabilitation
MindMaze, a global pioneer in the development of AI-driven digital neurotherapeutics, is proud to announce the US and EU launch of Izar®1, a first-of-its-kind, FDA-listed and CE-marked smart peripheral for patients with impairment in hand motor function. Izar is designed to fill a critical gap in neurological care today and aims to be the…
Read More7 digital health start-ups selected by the Future of Health Grant
CSS and EPFL announce the 2nd cohort of the Future of Health Program The Future of Health Grant (FoHG) programme of CSS and EPFL Innovation Park supports innovation in digital health. The 7 new start-ups selected from 96 applications will receive funding and expertise to accelerate the development of their solution. 7 start-ups…
Read MoreSEED Biosciences teams up with Molecular Device to market its DispenCell
Biopôle-based SEED Biosciences teams up with Molecular Devices, LLC. The American leading provider of high-performance life science solutions is now a commercial supplier of the DispenCell Single-Cell Dispenser in the US and Asia. Accurate single-cell isolation with immediate, traceable proof of monoclonality is critical to a successful cell line development process. However, isolating a…
Read MoreLonza wants to encourage careers In Life Sciences and opens MINTWorld
Faced with a shortage of qualified personnel in the field of mathematics, computer science, natural sciences and technology (MINT) in the Swiss Health Valley, Lonza and the Department of Economy and Education (DEF) of the canton of Valais have joined forces to create a discovery and innovation space for the promotion of MINT. Located…
Read MoreGene Predictis is bought by NIMGenetics
The EPFL-based start-up accepted the offer of the Spanish company. The amount of the transaction has not been disclosed. NIMGenetics, a leading Spanish biotechnology company in the field of human genetic diagnostics, continues its expansion in Europe with the acquisition of the Swiss diagnostic company Gene Predictis, a leader in the field of preventive…
Read MoreSOPHiA GENETICS Expands Partnership with AstraZeneca
The Swiss start-up, specialised in AI assisted medicine, and the Swedish-British pharmaceutical company want to create multimodal approaches for cancer drug development SOPHiA GENETICS SA, the creator of a leading cloud-native global data-sharing network and health analytics platform, is partnering with AstraZenecato apply their multimodal technology and expertise to the biopharmaceutical company’s oncology portfolio. The…
Read More13 biotech companies to watch according to BioAlps and Labiotech.eu
BioAlps recently collaborated with Labiotech.eu to detect the 13 biotech and healthtech companies in the Swiss Health Valley to watch in 2023. Adiposs Headquarters: Geneva Founded: 2020 Adiposs has developed ImageBAT, a first-in-class medical imaging product for brown adipose tissue. Brown fat plays a central role in human metabolism and has a big…
Read MoreLa Tour invests CHF 750 million in a health campus in Meyrin
Hôpital de La Tour in Geneva sells its premises to finance an ambitious innovation-oriented health campus The owners of the Hôpital de La Tour in Meyrin are pleased to announce that they have entered into a sale and leaseback agreement with a consortium of investors, advised by the bank Union Bancaire Privée – UBP…
Read MoreCHF 500 000 for AC Immune
Michael J. Fox Foundation for Parkinson’s Research (MJFF) and Target ALS Foundation (Target ALS) provide more than USD 500,000 in additional non-dilutive capital to the Swiss company AC Immune SA, a clinical-stage biopharmaceutical Swiss company pioneering precision medicine for neurodegenerative diseases, announced prestigious new grants from The Michael J. Fox Foundation for Parkinson’s Research (MJFF)…
Read MoreAspivix receives U.S. FDA Clearance for Carevix™, Their Novel Cervical Stabilizer
Carevix™, a novel atraumatic cervical stabilizer created by the Swiss startup ASPIVIX SA, received 510(k) clearance from the U.S. Food and Drug Administration (FDA). A more gentle and efficient tool for gynecology. Carevix™ is an atraumatic cervical stabilizer that utilizes a gentle approach to reduce pain and bleeding in multiple transcervical procedures, such as…
Read More